As the United States and world continue to fight the COVID-19 pandemic, America’s biopharmaceutical research companies continue to do our part in fighting this deadly virus. Decades of scientific innovation have allowed biopharmaceutical researchers to respond quickly and continue to research and develop treatments and vaccines for COVID-19. Importantly, the best strategy to prevent infection against COVID-19 is to get vaccinated. Three vaccines are currently available for protection against COVID-19, one of which was recently approved by The U.S. Food and Drug Administration (FDA) for use in certain populations. These vaccines are safe and have been administered to over a hundred million Americans, and billions around the world. To date, one antiviral is also currently approved by the FDA for use in patients 12 years of age and older for the treatment of COVID-19, which has the ability to speed recovery time by up to 5 days.
